Physician

Edward W Frank, M.D.

According to 2025 Medicare claims, Edward Frank, M.D. (NPI: 1053426015) practices dermatology in the Manchester-Nashua, NH market, with the plurality of this provider's patient population coming from Hillsborough, NH. This provider's primary affiliated billing organization is E WILLIAM FRANK MD DERMATOLOGY ASSOCIATES OF S NH (NPI: 1215023577; TIN: 020489238) and primary practice location at 03060-4758. Frank is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490), participating under the MSSP model.

Frank's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,107 traditional Medicare patients, billed 4,666 HCPCS/CPT codes, and received $361,723 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 114 prescription claims across 76 beneficiaries totaling $3,539 in drug costs, led by Fluorouracil (Fluorouracil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $634,099 to $361,723. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $19,300 to $3,539. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$317K$634K2015 Medicare payment: $634,099 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $594,842 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $522,688 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $500,024 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $448,003 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $381,154 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $441,439 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $424,064 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $383,470 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $361,723 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3515,735$634,099
20161,2785,187$594,842
20171,2115,251$522,688
20181,2815,958$500,024
20191,2435,736$448,003
20201,0865,501$381,154
20211,2515,680$441,439
20221,2225,135$424,064
20231,1264,809$383,470
20241,1074,666$361,723

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.6K$19K2015 Drug cost: $19,300 (USD; Tot_Drug_Cst)2016 Drug cost: $18,604 (USD; Tot_Drug_Cst)2017 Drug cost: $17,197 (USD; Tot_Drug_Cst)2018 Drug cost: $15,727 (USD; Tot_Drug_Cst)2019 Drug cost: $11,220 (USD; Tot_Drug_Cst)2020 Drug cost: $5,845 (USD; Tot_Drug_Cst)2021 Drug cost: $5,100 (USD; Tot_Drug_Cst)2022 Drug cost: $4,319 (USD; Tot_Drug_Cst)2023 Drug cost: $5,431 (USD; Tot_Drug_Cst)2024 Drug cost: $3,539 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015203308$19,300
2016241364$18,604
2017202308$17,197
2018192338$15,727
2019171281$11,220
202094141$5,845
2021101145$5,100
202275104$4,319
202390146$5,431
202476114$3,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth220253$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more796968$59
17000Destruction of precancer skin growth, 1 growth462585$42
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more217284$41
17003Destruction of precancer skin growth, 2-14 growths3321,387$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil14420$1,202
CephalexinCephalexin27121$252
Clobetasol PropionateClobetasol Propionate12313$232
Triamcinolone AcetonideTriamcinolone Acetonide14498$216

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Edward W. Frank, M.D.?

Tedicare shows public-source Medicare data for Edward W. Frank, M.D. (NPI 1053426015), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward W. Frank, M.D. have ACO affiliation data?

Edward W. Frank, M.D. is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490).

What billing organization is linked to Edward W. Frank, M.D.?

Edward W. Frank, M.D. is linked to E WILLIAM FRANK MD DERMATOLOGY ASSOCIATES OF S NH (billing NPI 1215023577) in the available physician profile data.

Does Edward W. Frank, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.